Biochemistry professor Joanne Lemieux leads a U of A team that identified promising compounds known as protease inhibitors that interfere with the SARS-CoV-2 virus’s ability to replicate — potentially pointing the way to new antiviral treatments that would be more effective with fewer toxic side-effects. (Photo: John Ulan)

U of A team uncovers new compounds to slow SARS-CoV-2 replication mechanism

Posted on

Novel protease inhibitors show promise for developing safer, more effective COVID-19 treatments.

A team of researchers at the University of Alberta has uncovered new antiviral agents that could lead to safer and more effective COVID-19 treatments than other current drugs under development….

https://www.ualberta.ca/folio/2021/10/u-of-a-team-uncovers-new-compounds-to-slow-sars-cov-2-replication-mechanism.html

 

Read More Impact Stories

Posted on
A comprehensive study by scientists at UdeM maps the evolutionary dynamics and risks of viral emergence of diseases that could [...]
Posted on
This article is available only in French. Infections respiratoires: mieux trier les patients pour soulager la pression sur les urgences [...]
Posted on
UBC’s Dr. James Lim is part of a research team helping to bring new hope to children battling hard-to-treat cancers. [...]